Ellen Madarang
@Ellen_cve
Hematology Oncology Clinical Pharmacist @SylvesterCancer 🙌🧡💚| Mom of 2 kids 👶🧒and 1 #AussieDoodle 🐶
Two ecstatic ✨Swifties✨ with their pins and their T-shirts excited for this weekend when @tswifterastour comes to Miami!!! @Ellen_cve @SylvesterCancer @UMiamiHealth #TheErasTour
Happy Birthday to the most amazing leukemia pharmacist, greatest mom, and bestest friend in the world @Ellen_cve!
Our new paper is out @Nature_NPJ Precision Oncology! rdcu.be/eujnK With @JustinWattsMD and colleagues @SylvesterCancer we report on the first patient functionally cured by single-agent IDH1 inhibition with Olutasidenib @RigelPharma for r/r #AML @NaturePortfolio 🧵
We kicked off our 4th Biennial Miami Leukemia Symposium with opening remarks from @MikkaelSekeres, Chief of Hematology Division at Sylvester. 🙌 We're proud to bring together global experts to Miami this weekend to advance #leukemia research and care. #leusm
And we’re off! @beatalleukemia gives a terrific talk on clinical implications of clonal hematopoiesis at the Miami Leukemia Symposium! @OhioState @SylvesterCancer @UMiamiHealth
We invite you to join us for our 4th Biennial Miami Leukemia Symposium! Featuring an exciting group of world-renowned clinicians and researchers, the symposium will offer a forum to explore a wide range of topics. Register today: loom.ly/H3uc_iw. @MikkaelSekeres…
New work led by @Anand_88_Patel featuring @HJohnstonMD as co-author in @BloodAdvances evaluating the use of AML risk criteria in patients with MPN-AP/BP getting less intensive therapy pubmed.ncbi.nlm.nih.gov/39969200/
So much fun at #DCC15 as we @TackleCancer with @SylvesterCancer Go Team Better Than Placebo and Team Heme! And special shoutout to my best friend @JillLykon for conquering 99 miles @TBradley_MD @MikkaelSekeres @TaylorJ_MD @DrPlatelet
Across the finish line @TackleCancer @SylvesterCancer #DCC15 with some truly wonderful people dedicated to eradicating cancer! @TaylorJ_MD @GlopesMd @Ellen_cve @DrPlatelet @HenriFordMD @UMiamiHealth
We're proud to present our 4th Biennial Miami Leukemia Symposium, featuring world-renowned #clinicians and #researchers discussing the modern management acute and chronic #leukemia, and the role of stem cell transplantation. Register today: loom.ly/H3uc_iw. 🙌
Hi PGY2 Heme Onc Pharmacy Residents - looking for inpatient hematology clin pharm job after graduation!? UM has a new position available just for you. It’s all about the 🙌🏼💚🧡 @UMiamiHealth @SylvesterCancer Apply here: careers.miami.edu/us/en/job/R100…
This #ASH24 presentation is a must watch, check it out on the virtual platform if you missed it in person. @SylvesterCancer @CUSystem @DanPollyea @JustinWattsMD @MikkaelSekeres @drsangeetmd @TBradley_MD @NamrataChandhok @TaylorJ_MD
CONGRESS | #ASH24 | PRESENTATION @DanPollyea, @CUSystem, discussed findings from a prospective, single-arm, phase II trial (NCT03573024) of venetoclax + azacitidine in patients with newly diagnosed AML. The study was stopped at Stage 3 (n=27) as the ORR (67%) did not meet the…
Outstanding presentation on trial of AZA + Ven in younger #AMLsm adults by @DanPollyea #ASH24. Proud to be part of this collaboration @SylvesterCancer @UMiamiHealth! ORR 69%, MRD- 64% @ASH_hematology
Full performance of Taylor ending the VERY LAST NIGHT of The Eras Tour with “Long Live” x “New Year’s Day” x “The Manuscript” on the piano 🤍🥺 #VancouverTSTheErasTour
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations ow.ly/aCzC50Ucl9o #specialreport #myeloidneoplasia
Our @SylvesterCancer research team cheering on our @MiamiHurricanes 🙌💚🧡
Leukemia Team 🙌 @SylvesterCancer @TBradley_MD @MikkaelSekeres @JustinWattsMD @drsangeetmd @Maryam_Alasfour
🎸 Thanks to DCC (@TackleCancer) & supporters, pediatric cancer patients at Sylvester attended @taylorswift13’s Eras Tour at @HardRockStadium! “It was such a special experience,” said @DrSDNimer, now a proud “Swiftie.” ✨ Read more: loom.ly/2FLZMIg. #MiamiTSTheErasTour